DK1572178T3 - Behandling af mastalgi med 4-hydroxytamoxifen - Google Patents

Behandling af mastalgi med 4-hydroxytamoxifen

Info

Publication number
DK1572178T3
DK1572178T3 DK03813146T DK03813146T DK1572178T3 DK 1572178 T3 DK1572178 T3 DK 1572178T3 DK 03813146 T DK03813146 T DK 03813146T DK 03813146 T DK03813146 T DK 03813146T DK 1572178 T3 DK1572178 T3 DK 1572178T3
Authority
DK
Denmark
Prior art keywords
mastalgia
treatment
hydroxytamoxifen
hydroxy tamoxifen
percutaneously
Prior art date
Application number
DK03813146T
Other languages
English (en)
Inventor
Lignieres Bruno De
Original Assignee
Besins Int Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Int Lab filed Critical Besins Int Lab
Application granted granted Critical
Publication of DK1572178T3 publication Critical patent/DK1572178T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
DK03813146T 2002-12-18 2003-12-15 Behandling af mastalgi med 4-hydroxytamoxifen DK1572178T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43395902P 2002-12-18 2002-12-18

Publications (1)

Publication Number Publication Date
DK1572178T3 true DK1572178T3 (da) 2006-09-11

Family

ID=32595255

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03813146T DK1572178T3 (da) 2002-12-18 2003-12-15 Behandling af mastalgi med 4-hydroxytamoxifen

Country Status (16)

Country Link
US (1) US7786172B2 (da)
EP (1) EP1572178B1 (da)
JP (1) JP4938237B2 (da)
AT (1) ATE324880T1 (da)
AU (1) AU2003303033B2 (da)
CA (1) CA2509660C (da)
CY (1) CY1106131T1 (da)
DE (1) DE60305068T2 (da)
DK (1) DK1572178T3 (da)
ES (1) ES2263072T3 (da)
HK (1) HK1075403A1 (da)
MX (1) MXPA05006526A (da)
NZ (1) NZ540494A (da)
PT (1) PT1572178E (da)
SI (1) SI1572178T1 (da)
WO (1) WO2004054557A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60327363D1 (de) * 2002-12-18 2009-06-04 Besins Int Lab Verringerung der dichte des brustgewebes durch 4-hydroxy tamoxifen
EP1952810B1 (en) * 2003-04-01 2014-01-08 Besins Healthcare Luxembourg SARL Treatment of breast cancer with 4-hydroxytamoxifen
JP4682129B2 (ja) * 2003-06-09 2011-05-11 アセンド セラピュティクス インコーポレイテッド ４−ヒドロキシタモキシフェンによる過剰瘢痕化の治療及び予防
US7968532B2 (en) * 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
JP5072588B2 (ja) * 2004-03-22 2012-11-14 ラボラトワール ブザン アンテルナスィヨナル ４−ヒドロキシタモキシフェンを用いた良性乳房疾患の治療および予防
EP1579856A1 (en) * 2004-03-22 2005-09-28 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
EP1579857A1 (en) * 2004-03-22 2005-09-28 Laboratoires Besins International Chemically stable compositions of 4-hydroxy tamoxifen
EP1647271A1 (en) * 2004-10-14 2006-04-19 Laboratoires Besins International 4-Hydroxy tamoxifen gel formulations
DE602005011314D1 (de) * 2004-10-14 2009-01-08 Besins Int Lab 4-hydroxytamoxifengel-formulierungen
PL1919290T3 (pl) * 2005-07-12 2014-06-30 Ampio Pharmaceuticals Inc Sposoby i produkty do leczenia chorób
DE202010017530U1 (de) 2009-06-22 2012-03-28 Dmi Acquisition Corp. Danazolverbindung zur Behandlung von Krankheiten
KR20150105355A (ko) 2012-12-19 2015-09-16 앰피오 파마슈티컬스 인코퍼레이티드 질병을 치료하기 위한 방법
AU2018329202B2 (en) 2017-09-11 2022-10-27 Atossa Therapeutics, Inc. Methods for making and using endoxifen

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
EP0287690B1 (de) * 1987-04-21 1992-09-02 HEUMANN PHARMA GMBH & CO Stabile Lösungsmitteladdukte von Z-1-(p-beta-Dimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl)-2-phenylbut-1-en
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
DE3836862A1 (de) 1988-10-27 1990-05-03 Schering Ag Mittel zur transdermalen applikation von steroidhormonen
US5189212A (en) * 1990-09-07 1993-02-23 University Of Georgia Research Foundation, Inc. Triarylethylene carboxylic acids with estrogenic activity
TW218849B (da) 1991-05-17 1994-01-11 Bristol Myers Squibb Co
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
US5720963A (en) * 1994-08-26 1998-02-24 Mary Kay Inc. Barrier disruption treatments for structurally deteriorated skin
IL120268A0 (en) * 1996-02-28 1997-06-10 Pfizer Use of (E)-1-[4'-(2-alkylaminoethioxy)phenyl]1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions
IL120266A (en) 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
US6548491B2 (en) * 1997-12-24 2003-04-15 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6013270A (en) * 1998-04-20 2000-01-11 The Procter & Gamble Company Skin care kit
ATE290856T1 (de) * 1999-12-16 2005-04-15 Dermatrends Inc Hydroxide freisetzende verbindungen zum verbessern der hautdurchlässigkeit
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
EP1177787A3 (en) * 2000-07-28 2003-09-10 Pfizer Products Inc. Use of an estrogen agonist/antagonist for treating cataracts
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
DE10054294A1 (de) 2000-11-02 2002-05-16 Heinrich Wieland Topische Behandlung bei der Mastalgie
DE60108710T2 (de) * 2000-11-30 2006-05-04 Pfizer Products Inc., Groton Östrogen Agonist-Antagonist und Testosteron enthaltende Zusammensetzung zur Behandlung abnehmender Testosteronspiegel
JP2005504032A (ja) * 2001-07-31 2005-02-10 ファイザー・プロダクツ・インク エストロゲン・アゴニスト／アンタゴニスト、エストロゲン及びプロゲスチンの組み合わせを含む医薬組成物、キット及び方法
DE60139625D1 (de) * 2001-12-07 2009-10-01 Besins Int Belgique Gel oder Lösung enthaltend Dihydrotestosterone, deren Herstellungsverfahren und Verwendung
DE60327363D1 (de) * 2002-12-18 2009-06-04 Besins Int Lab Verringerung der dichte des brustgewebes durch 4-hydroxy tamoxifen
EP1952810B1 (en) * 2003-04-01 2014-01-08 Besins Healthcare Luxembourg SARL Treatment of breast cancer with 4-hydroxytamoxifen
JP4682129B2 (ja) 2003-06-09 2011-05-11 アセンド セラピュティクス インコーポレイテッド ４−ヒドロキシタモキシフェンによる過剰瘢痕化の治療及び予防
US7968532B2 (en) * 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
EP1579856A1 (en) 2004-03-22 2005-09-28 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
EP1579857A1 (en) 2004-03-22 2005-09-28 Laboratoires Besins International Chemically stable compositions of 4-hydroxy tamoxifen
EP1647271A1 (en) * 2004-10-14 2006-04-19 Laboratoires Besins International 4-Hydroxy tamoxifen gel formulations

Also Published As

Publication number Publication date
ATE324880T1 (de) 2006-06-15
CA2509660A1 (en) 2004-07-01
JP2006514949A (ja) 2006-05-18
CY1106131T1 (el) 2011-06-08
ES2263072T3 (es) 2006-12-01
MXPA05006526A (es) 2006-02-17
EP1572178B1 (en) 2006-05-03
NZ540494A (en) 2007-05-31
CA2509660C (en) 2011-08-30
SI1572178T1 (sl) 2006-10-31
PT1572178E (pt) 2006-09-29
US20050032909A1 (en) 2005-02-10
DE60305068D1 (de) 2006-06-08
JP4938237B2 (ja) 2012-05-23
US7786172B2 (en) 2010-08-31
WO2004054557A3 (en) 2004-08-05
AU2003303033B2 (en) 2009-06-04
DE60305068T2 (de) 2007-01-11
AU2003303033A1 (en) 2004-07-09
HK1075403A1 (en) 2005-12-16
WO2004054557A2 (en) 2004-07-01
EP1572178A2 (en) 2005-09-14

Similar Documents

Publication Publication Date Title
HK1075403A1 (en) Treatment of mastalgia with 4-hydroxy tamoxifen
CZ2006579A3 (cs) Kožní mikroaktivační systém
WO2004054558A3 (en) Reduction of breast density with 4-hydroxy tamoxifen
EA200802213A1 (ru) Способы лечения заболеваний крови
SE0101387D0 (sv) Novel compounds
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
DK1797053T3 (da) Phenothiazinium-forbindelse til sårheling
TW200637529A (en) Topical patch cooling preparation and methods for using the same
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
BRPI0607605A2 (pt) moléculas imunogênicas
EA200870091A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для снятия боли
BRPI0519218A2 (pt) reduÇço do crescimento de cabelos ou pÊlos
BRPI0415781A (pt) método para o tratamento de diabetes em um paciente e kit farmacêutico
NO20051261L (no) Morfin-6-glukuronidsalt
DK1644076T3 (da) Topisk sammensætning til behandling af akne og rosacea med galvanisk genereret elektricitet
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
DE602004025683D1 (de) Therapeutische zubereitung für autoimmune erkrankungen
ATE545421T1 (de) Pharmazeutisches präparat zur behandlung von parasitären tropenkrankheiten enthaltend diminazen-di-aceturat
EA200700834A1 (ru) Рецептура геля с 4-гидрокситамоксифеном
DE602005018941D1 (de) Verwendung von winterbohnenkraut (satureja montana) oder seinen extrakten zur herstellung von medikamenten zur behandlung von vorzeitiger ejakulation
NO20062138L (no) Anvendelse av ifenprodil i behandling av smerte
EA200501059A1 (ru) Способ защиты кожи
ITMI20040145A1 (it) L-moprololo lpiu' tartrato
SE0203563D0 (sv) Natrumedel med smärtlindrande egenskap
UA3958U (uk) Спосіб лікування хронічного гастродуоденіту з супутнім хронічним холециститом